Antimetastatic Effects of Curcumin in Oral and Gastrointestinal Cancers

(2021) Antimetastatic Effects of Curcumin in Oral and Gastrointestinal Cancers. FRONTIERS IN PHARMACOLOGY. ISSN 1663-9812 J9 - FRONT PHARMACOL

Full text not available from this repository.

Abstract

Gastrointestinal (GI) cancers are known as frequently occurred solid malignant tumors that can cause the high rate mortality in the world. Metastasis is a significant destructive feature of tumoral cells, which directly correlates with decreased prognosis and survival. Curcumin, which is found in turmeric, has been identified as a potent therapeutic natural bioactive compound (Curcuma longa). It has been traditionally applied for centuries to treat different diseases, and it has shown efficacy for its anticancer properties. Numerous studies have revealed that curcumin inhibits migration and metastasis of GI cancer cells by modulating various genes and proteins, i.e., growth factors, inflammatory cytokines and their receptors, different types of enzymes, caspases, cell adhesion molecules, and cell cycle proteins. Herein, we summarized the antimetastatic effects of curcumin in GI cancers, including pancreatic cancer, gastric cancer, colorectal cancer, oral cancer, and esophageal cancer.

Item Type: Article
Keywords: gastrointestinal cancer (GI cancer) curcumin therapy metastasis gastric cancer EPITHELIAL-MESENCHYMAL TRANSITION SQUAMOUS-CELL CARCINOMA GROWTH-FACTOR RECEPTOR LIPOCURC(TM) LIPOSOMAL CURCUMIN NATURAL COMPOUND TARGETS HUMAN PANCREATIC-CANCER B-MEDIATED INDUCTION COLORECTAL-CANCER E-CADHERIN MATRIX-METALLOPROTEINASE
Journal or Publication Title: FRONTIERS IN PHARMACOLOGY
Journal Index: ISI
Volume: 12
Identification Number: https://doi.org/10.3389/fphar.2021.668567
ISSN: 1663-9812 J9 - FRONT PHARMACOL
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/17685

Actions (login required)

View Item View Item